Relief Cardiovascular has closed a $12 million Series A round to help initiate a first-in-human feasibility study for its ...

Start the day smarter. Get all the news you need in your inbox each morning. From wireless wearables and ...

Norm has received breakthrough device designation from the Food and Drug Administration, giving Fire1 additional access to the agency as it works to bring the product to market. The early feasibility ...